Cat. No.: X23-10-ZQ811
TGF-β-Smad inhibitor LY2157299, Purity ≥98%
Synonym: Galunisertib; 700874-72-2; LY2157299; LY 2157299; LY-2157299; 4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide; TGF-β-Smad inhibitor
- MDL: MFCD12923319
- CAS Number: 700874-72-2
- Compound CID: 10090485
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
LY2157299, soluble in DMSO and insoluble in ethanol and water, is a potent and specific inhibitor of TGF-β-Smad signaling pathway activation. It targets TβRI.
Molecular Formula
C22H19N5O
Solubility
DMSO: 66 mg/mL (178.65 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
LY2157299 can be used to study its inhibition of TGF-β receptor I kinase and its potential therapeutic applications in fibrosis and cancer.
Related Products
Quick Links